Loading...
ReadMe DNAReadMe DNASample Report — This report was generated from anonymized test data. Upload your own DNA file to get personalized results.
23andMe · 9 categories · 157 findings
Top Actions
18 findings · 18 genes tracked
Key finding: Reduced beta-carotene to vitamin A conversion
You carry two copies of the T variant (267S) in the BCMO1 gene, which encodes the primary enzyme that converts beta-carotene into retinal (a form of vitamin A).
💡 Action: Include preformed vitamin A sources (eggs, dairy, liver, fatty fish) in your diet rather than relying solely on beta-carotene from plant foods.
You carry two copies of the T allele (Val16) in SOD2, which encodes manganese superoxide dismutase — the primary antioxidant defense inside mitochondria.
💡 Action: Emphasize antioxidant-rich foods (berries, leafy greens, nuts, seeds) and adequate manganese intake (whole grains, nuts, legumes).
You carry two copies of the C allele (Ala736) at TMPRSS6 rs855791.
💡 Action: Ensure adequate dietary iron from both heme (red meat, poultry) and non-heme sources (legumes, fortified cereals).
You carry two copies of the T allele (Thr235) in AGT, which encodes angiotensinogen — the precursor to angiotensin II, a potent vasoconstrictor.
💡 Action: Monitor your sodium intake and aim for the recommended limit of 2,300mg/day or less.
You carry two copies of the G allele at the VKORC1 promoter variant (-1639G>A).
💡 Action: Standard dietary vitamin K intake through green leafy vegetables is appropriate.
17 findings · 17 genes tracked
Key finding: AGT Thr235 — higher angiotensinogen and BP risk
You carry two T alleles (Thr235Thr) at AGT rs699, associated with approximately 20% higher circulating angiotensinogen levels.
💡 Action: Regular aerobic exercise is especially beneficial for blood pressure management at your genotype.
You carry two copies of the G allele at IL6 -174, associated with higher interleukin-6 production.
💡 Action: Pay attention to recovery between intense sessions.
You carry two copies of the T allele at GDF5 rs143383, associated with reduced GDF5 (growth differentiation factor 5) expression.
💡 Action: Protect your joints: maintain a healthy weight, include low-impact cross-training, strengthen muscles around major joints, and avoid excessive high-impact activities.
You carry two A alleles at MMP3 rs679620, associated with higher matrix metalloproteinase-3 (stromelysin-1) production.
💡 Action: Be mindful of gradual load progression in running and jumping activities.
You carry two C alleles at CRP rs1205, associated with higher baseline C-reactive protein levels.
💡 Action: Monitor your recovery and fatigue levels.
17 findings · 16 genes tracked
Key finding: Typical TNF-alpha levels — lower inflammation-related sleep risk
You carry the GG genotype at TNF rs1800629 (-308G/A).
💡 Action: Your TNF genetics do not independently elevate sleep apnea risk.
You carry the common CC genotype at PER2 rs2304672.
💡 Action: This genotype does not indicate atypical circadian timing.
You carry the common CC genotype at PER3 rs228697, which tags the 4-repeat allele of the PER3 variable-number tandem repeat (VNTR).
💡 Action: You may tolerate occasional short sleep better than average, but consistent 7-9 hours remains recommended for long-term health..
You carry the common CC genotype at ADA rs73598374 (Asp8Asp).
💡 Action: Your adenosine metabolism is typical.
You carry the common GG genotype at MEIS1 rs2300478.
💡 Action: Your MEIS1 genotype does not elevate RLS risk.
19 findings · 20 genes tracked
Key finding: OVOL1 risk genotype — increased eczema susceptibility
You carry two copies of the G allele at OVOL1 rs479844, identified as a risk allele for atopic dermatitis in large GWAS.
💡 Action: Maintain a consistent skin barrier care routine: moisturize regularly, use gentle skincare products, and minimize irritant exposure to reduce eczema risk..
You carry two copies of the common G allele at COL1A1 rs1800012 (the Sp1 binding site polymorphism in the first intron).
💡 Action: Your collagen genetics at this locus are typical.
You carry two copies of the common allele at IRF4 rs12203592.
💡 Action: Standard sun protection measures are appropriate based on this variant..
You carry two copies of the derived C allele (Leu374) at SLC45A2.
💡 Action: Lighter skin pigmentation means less natural UV protection.
You carry two copies of the derived A allele (Thr111) at SLC24A5.
💡 Action: This is a very common European variant.
12 findings · 12 genes tracked
Key finding: Normal aldehyde dehydrogenase activity
You carry two copies of the functional Glu504 allele (G allele) in ALDH2, which encodes mitochondrial aldehyde dehydrogenase 2 — the enzyme primarily responsible for metabolizing acetaldehyde, a toxic intermediate of alcohol breakdown.
💡 Action: Normal ALDH2 activity does not mean alcohol is risk-free.
You carry two copies of the Ile191 allele (C allele) at TAS1R2, a gene encoding one subunit of the sweet taste receptor heterodimer (TAS1R2/TAS1R3).
💡 Action: Your sweet taste perception is in the typical range.
You carry two copies of the Thr110 allele (C allele) in SLC2A2, which encodes the GLUT2 glucose transporter expressed in the intestine, liver, pancreas, and brain.
💡 Action: Your genotype is associated with typical sugar-sensing patterns.
You carry two copies of the common allele (G) at rs34160967 in TAS1R1, which encodes one subunit of the umami (savory) taste receptor.
💡 Action: Your umami taste perception is typical.
You carry two copies of the common C allele at rs307355 in the promoter region of TAS1R3, which encodes the shared subunit of both the sweet (TAS1R2/TAS1R3) and umami (TAS1R1/TAS1R3) taste receptors.
💡 Action: Your TAS1R3 promoter genotype is common and associated with typical sweet/umami receptor expression.
18 findings · 18 genes tracked
Key finding: Normal warfarin dose requirement at VKORC1
You carry the GG genotype at the VKORC1 -1639G>A locus, associated with normal VKORC1 expression and a standard warfarin dose requirement.
💡 Action: If prescribed warfarin, your VKORC1 genotype suggests a typical-to-higher dose requirement, but CYP2C9 status and clinical factors also matter.
You are homozygous for the Val158 allele of COMT, giving you roughly 3–4 times higher enzyme activity than Met/Met individuals.
💡 Action: This genotype may be relevant to psychiatric medication selection and pain management approaches.
You do not carry the CYP2C19*17 gain-of-function promoter variant.
💡 Action: Standard dosing of SSRIs and PPIs is generally appropriate at this locus.
You do not carry the variant at rs1065852, which contributes to the CYP2D6*4 haplotype in Europeans and defines the *10 allele common in East Asians.
💡 Action: Normal CYP2D6 function expected at this locus.
You carry the common AA genotype at the OPRM1 Asn40Asp locus, encoding the asparagine (Asn) amino acid at position 40 of the mu-opioid receptor.
💡 Action: Standard opioid dosing protocols apply.
13 findings · 13 genes tracked
Key finding: Two MC1R red hair alleles — likely red hair phenotype
You carry two copies of the MC1R R151C variant, which strongly predicts red hair, very fair skin, and abundant freckling.
💡 Action: This is an ancestry-informative marker strongly associated with Northern/Western European (especially Celtic) ancestry.
You carry two copies of the functional ALDH2*1 allele, which produces a fully active aldehyde dehydrogenase 2 enzyme.
💡 Action: This is an ancestry-informative marker.
You carry two copies of the ancestral C allele (Phe374) at SLC45A2, the original human state.
💡 Action: This is an ancestry-informative marker consistent with sub-Saharan African, East Asian, Southeast Asian, or Indigenous American ancestry..
You carry two copies of the derived A allele (Thr111), which is associated with substantially lighter skin pigmentation.
💡 Action: This is an ancestry-informative marker consistent with European, South Asian, Middle Eastern, or North African ancestry.
You carry two copies of the derived G allele in the HERC2 gene, which acts as a regulatory switch reducing expression of the nearby OCA2 pigmentation gene in the iris.
💡 Action: This is an ancestry-informative marker strongly associated with Northern European ancestry.
17 findings · 17 genes tracked
Key finding: Higher serotonin 2A receptor expression
You carry two G alleles at the HTR2A promoter variant rs6311.
💡 Action: This is a normal variant.
You carry two copies of the Val allele (Val/Val) at COMT Val158Met.
💡 Action: Your cognition may actually improve under moderate stress.
You carry no copies of the Taq1A A1 allele (A2/A2 genotype).
💡 Action: Your dopamine reward circuitry is typical.
You carry two copies of the T allele in the DRD4 promoter region.
💡 Action: This is a normal variant.
You carry two G alleles at rs4570625 in TPH2, the rate-limiting enzyme for serotonin synthesis in the brain.
💡 Action: No specific action is needed.
26 findings · 26 genes tracked
Key finding: Higher IL-6 expression genotype
You carry the GG genotype at IL6 rs1800795 (-174G/C), which is associated with higher IL-6 cytokine production.
💡 Action: Consider anti-inflammatory lifestyle practices: regular exercise, omega-3 rich diet, adequate sleep, and stress management.
You carry the CC genotype at CRP rs1205, associated with higher baseline C-reactive protein levels.
💡 Action: Consider periodic hs-CRP testing as part of cardiovascular risk assessment.
You carry the CC genotype at PPARG rs1801282 (Pro12Ala), meaning you have the Pro/Pro version.
💡 Action: A typical result.
You carry the CC genotype at SLC30A8 rs13266634 (R325W), encoding the arginine (R325) version.
💡 Action: A typical result.
You carry the GG genotype at TNF rs1800629 (-308G/A), the most common genotype (~73% of Europeans).
💡 Action: A typical result.
Include preformed vitamin A sources (eggs, dairy, liver, fatty fish) in your diet rather than relying solely on beta-carotene from plant foods. Pair carotenoid-rich foods with dietary fat to enhance absorption.
From: Reduced beta-carotene to vitamin A conversion
Emphasize antioxidant-rich foods (berries, leafy greens, nuts, seeds) and adequate manganese intake (whole grains, nuts, legumes). Minimize excessive oxidative stressors like smoking and heavy alcohol use.
From: Reduced mitochondrial antioxidant enzyme import
Ensure adequate dietary iron from both heme (red meat, poultry) and non-heme sources (legumes, fortified cereals). Pair non-heme iron with vitamin C to enhance absorption. Consider having your iron levels checked if you experience fatigue or other symptoms. Consult your healthcare provider if concerned.
From: Lower iron and hemoglobin levels
Monitor your sodium intake and aim for the recommended limit of 2,300mg/day or less. Emphasize potassium-rich foods (bananas, potatoes, leafy greens) to help counterbalance sodium's effects. Have your blood pressure checked regularly. Consult your healthcare provider for personalized guidance.
From: Higher angiotensinogen and salt sensitivity
Regular aerobic exercise is especially beneficial for blood pressure management at your genotype. Monitor your blood pressure, moderate sodium intake, and discuss cardiovascular health with your healthcare provider, particularly if you have a family history of hypertension.
From: AGT Thr235 — higher angiotensinogen and BP risk
Pay attention to recovery between intense sessions. Anti-inflammatory nutrition (omega-3s, colorful fruits and vegetables) and adequate sleep may help manage inflammation.
From: Higher IL-6 response — stronger inflammatory signaling
Protect your joints: maintain a healthy weight, include low-impact cross-training, strengthen muscles around major joints, and avoid excessive high-impact activities. Consult your healthcare provider if you develop persistent joint pain.
From: Reduced GDF5 — elevated joint injury risk
Be mindful of gradual load progression in running and jumping activities. Eccentric strengthening exercises may help maintain tendon structural integrity.
From: Higher MMP3 activity — increased tendon remodeling
Monitor your recovery and fatigue levels. Regular moderate exercise actually lowers CRP over time. A diet rich in anti-inflammatory foods (fatty fish, vegetables, whole grains) may help keep baseline CRP in check.
From: Higher baseline CRP — stronger inflammatory marker
Include tendon-conditioning exercises (heavy slow resistance, eccentric loading) in your program, especially if you participate in running or jumping sports.
From: TNC variant — possible tendon injury susceptibility
Consider anti-inflammatory lifestyle practices: regular exercise, omega-3 rich diet, adequate sleep, and stress management. If you have inflammatory conditions, discuss monitoring IL-6 or CRP levels with your healthcare provider.
From: Higher IL-6 expression genotype
Consider periodic hs-CRP testing as part of cardiovascular risk assessment. Anti-inflammatory lifestyle factors — regular exercise, healthy weight, omega-3 intake, and stress management — can help lower CRP levels regardless of genotype.
From: Higher baseline CRP levels genotype
This is an ancestry-informative marker strongly associated with Northern/Western European (especially Celtic) ancestry. Two MC1R loss-of-function variants are associated with increased melanoma risk independent of UV exposure. Practice diligent sun protection and regular skin checks. Consult your healthcare provider about appropriate melanoma screening.
From: Two MC1R red hair alleles — likely red hair phenotype
Maintain a consistent skin barrier care routine: moisturize regularly, use gentle skincare products, and minimize irritant exposure to reduce eczema risk.
From: OVOL1 risk genotype — increased eczema susceptibility
Allebrandt KV, Amin N, Muller-Myhsok B et al. (2013). “A KATP channel gene effect on sleep duration: from genome-wide association studies to function in Drosophila” Molecular Psychiatry. DOI: 10.1038/mp.2011.142 PMID: 22105623
Altshuler D, Hirschhorn JN, Klannemark M et al. (2000). “The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes” Nature Genetics. DOI: 10.1038/75812 PMID: 10614702
Altshuler D, Hirschhorn JN, Klannemark M et al. (2000). “The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes” Nature Genetics. DOI: 10.1038/79216 PMID: 10973253
Amstutz U, Henricks LM, Offer SM et al. (2018). “Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing: 2017 update” Clinical Pharmacology and Therapeutics. DOI: 10.1002/cpt.911 (not indexed in PubMed)
Barzilai N, Atzmon G, Schechter C et al. (2003). “Unique lipoprotein phenotype and genotype associated with exceptional longevity” JAMA. DOI: 10.1001/jama.290.15.2030 PMID: 14612481
Benyamin B, Ferreira MA, Willemsen G et al. (2009). “Common variants in TMPRSS6 are associated with iron status and erythrocyte volume” Nature Genetics. DOI: 10.1038/ng.456 PMID: 19820697
Binder EB, Salyakina D, Lichtner P et al. (2004). “Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment” Nature Genetics. DOI: 10.1038/ng1479 (not indexed in PubMed)
Birdwell KA, Decker B, Barbarino JM et al. (2015). “Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for CYP3A5 genotype and tacrolimus dosing” Clinical Pharmacology and Therapeutics. DOI: 10.1002/cpt.113 (not indexed in PubMed)
Bodenmann S, Rusterholz T, Durr R et al. (2009). “The functional Val158Met polymorphism of COMT predicts interindividual differences in brain alpha oscillations in young men” Journal of Neuroscience. DOI: 10.1523/JNEUROSCI.1528-09.2009 (not indexed in PubMed)
Bradley RG, Binder EB, Epstein MP et al. (2008). “Influence of child abuse on adult depression: moderation by the corticotropin-releasing hormone receptor gene” Archives of General Psychiatry. DOI: 10.1001/archgenpsychiatry.2007.26 (not indexed in PubMed)
Branicki W, Brudnik U, Wojas-Pelc A (2009). “Interactions between HERC2, OCA2 and MC1R may influence human pigmentation phenotype” Annals of Human Genetics. DOI: 10.1111/j.1469-1809.2009.00504.x PMID: 19456322
Brooks PJ, Enoch MA, Goldman D et al. (2009). “The alcohol flushing response: an unrecognized risk factor for esophageal cancer from alcohol consumption” PLoS Medicine. DOI: 10.1371/journal.pmed.1000050 PMID: 19320537
Brooks PJ, Enoch MA, Goldman D et al. (2009). “The alcohol flushing response: an unrecognized risk factor for esophageal cancer from alcohol consumption” PLoS Medicine. DOI: 10.1371/journal.pmed.1000050 (not indexed in PubMed)
Brown SM, Peet E, Manuck SB et al. (2005). “A regulatory variant of the human tryptophan hydroxylase-2 gene biases amygdala reactivity” Molecular Psychiatry. DOI: 10.1038/sj.mp.4001716 (not indexed in PubMed)
Bufe B, Breslin PAS, Kuhn C, Reed DR, Tharp CD, Slack JP, Kim UK, Drayna D, Meyerhof W (2005). “The molecular basis of individual differences in phenylthiocarbamide and propylthiouracil bitterness perception” Current Biology. DOI: 10.1016/j.cub.2005.01.047 PMID: 15723792
Cantero-Recasens G, Gonzalez JR, Fandos C, Duran-Tauleria E, Smit LA, Kauffmann F, Anto JM, Valverde MA (2010). “Loss of function of transient receptor potential vanilloid 1 (TRPV1) genetic variant is associated with lower risk of active childhood asthma” Journal of Biological Chemistry. DOI: 10.1074/jbc.M110.116111 (not indexed in PubMed)
Capon F, Di Meglio P, Szaub J et al. (2007). “Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasis” Human Genetics. DOI: 10.1007/s00439-007-0397-0 PMID: 17657509
Carlson CS, Aldred SF, Lee PK et al. (2005). “Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels” American Journal of Human Genetics. DOI: 10.1086/428440 (not indexed in PubMed)
Carpen JD, Archer SN, Skene DJ et al. (2005). “A single-nucleotide polymorphism in the 5'-untranslated region of the hPER2 gene is associated with diurnal preference” Journal of Sleep Research. DOI: 10.1111/j.1365-2869.2005.00471.x PMID: 16364138
Chen QY, Alarcon S, Tharp A, Ahmed OM, Estrella NL, Greene TA, Rucker J, Breslin PAS (2009). “Perceptual variation in umami taste and polymorphisms in TAS1R taste receptor genes” American Journal of Clinical Nutrition. DOI: 10.3945/ajcn.2009.27462N PMID: 19587085
Clarke R, Peden JF, Hopewell JC et al. (2009). “Genetic variants associated with Lp(a) lipoprotein level and coronary disease” New England Journal of Medicine. DOI: 10.1056/NEJMoa0902604 PMID: 20032323
Codd V, Nelson CP, Albrecht E et al. (2013). “Identification of seven loci affecting mean telomere length and their association with disease” Nature Genetics. DOI: 10.1038/ng.2528 PMID: 23535734
Coffee and Caffeine Genetics Consortium, Cornelis MC, Byrne EM et al. (2015). “Genome-wide meta-analysis identifies six novel loci associated with habitual coffee consumption” Molecular Psychiatry. DOI: 10.1038/mp.2014.107 PMID: 25288136
Cohen JC, Boerwinkle E, Mosley TH et al. (2006). “Sequence variations in PCSK9, low LDL, and protection against coronary heart disease” New England Journal of Medicine. DOI: 10.1056/NEJMoa054013 PMID: 16554528
Cornelis MC, El-Sohemy A, Kabagambe EK et al. (2006). “Coffee, CYP1A2 genotype, and risk of myocardial infarction” JAMA. DOI: 10.1001/jama.295.10.1135 (not indexed in PubMed)
Crews KR, Gaedigk A, Dunnenberger HM et al. (2014). “Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update” Clinical Pharmacology and Therapeutics. DOI: 10.1038/clpt.2013.254 (not indexed in PubMed)
da Costa KA, Kozyreva OG, Song J et al. (2006). “Common genetic polymorphisms affect the human requirement for the nutrient choline” FASEB Journal. DOI: 10.1096/fj.06-5734com PMID: 16807371
Dehghan A, Dupuis J, Barbalic M et al. (2011). “Meta-analysis of genome-wide association studies in >80 000 subjects identifies multiple loci for C-reactive protein levels” Circulation. DOI: 10.1161/CIRCULATIONAHA.110.948570 (not indexed in PubMed)
Dias AG, Pinnock J, Bhatt K, El-Sohemy A (2015). “Variation in the TAS1R2 gene, sweet taste perception and intake of sugars” Journal of Nutrigenetics and Nutrigenomics. (not indexed in PubMed)
Dincheva I, Drysdale AT, Hartley CA et al. (2015). “FAAH genetic variation enhances fronto-amygdala function in mouse and human” Nature Communications. DOI: 10.1038/ncomms7395 (not indexed in PubMed)
Duerr RH, Taylor KD, Brant SR et al. (2006). “A genome-wide association study identifies IL23R as an inflammatory bowel disease gene” Science. DOI: 10.1126/science.1135245 PMID: 17068223
Edwards M, Bigham A, Tan J et al. (2010). “Association of the OCA2 polymorphism His615Arg with melanin content in East Asian populations: further evidence of convergent evolution of skin pigmentation” PLoS Genetics. DOI: 10.1371/journal.pgen.1000867 (not indexed in PubMed)
Egan MF, Goldberg TE, Kolachana BS et al. (2001). “Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia” Proceedings of the National Academy of Sciences. DOI: 10.1073/pnas.091099198 PMID: 11381111
Egan MF, Kojima M, Callicott JH et al. (2003). “The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function” Cell. DOI: 10.1016/S0092-8674(03)00035-7 PMID: 12553913
Eiberg H, Troelsen J, Nielsen M et al. (2008). “Blue eye color in humans may be caused by a perfectly associated founder mutation in a regulatory element located within the HERC2 gene inhibiting OCA2 expression” Human Genetics. DOI: 10.1007/s00439-007-0460-x (not indexed in PubMed)
Eiberg H, Troelsen J, Nielsen M et al. (2008). “Blue eye color in humans may be caused by a perfectly associated founder mutation in a regulatory element located within the HERC2 gene inhibiting OCA2 expression” Human Genetics. DOI: 10.1007/s00439-007-0460-x PMID: 18172690
Enattah NS, Sahi T, Savilahti E et al. (2002). “Identification of a variant associated with adult-type hypolactasia” Nature Genetics. DOI: 10.1038/ng826 (not indexed in PubMed)
Eny KM, Wolever TM, Fontaine-Bisson B, El-Sohemy A (2008). “Genetic variant in the glucose transporter type 2 is associated with higher intakes of sugars in two distinct populations” Physiological Genomics. DOI: 10.1152/physiolgenomics.00148.2007 PMID: 18349384
Eriksson N, Macpherson JM, Tung JY, Hon LS, Naughton B, Saxonov S, Avey L, Wojcicki A, Pe'er I, Mountain J (2010). “Web-based, participant-driven studies yield novel genetic associations for common traits” PLoS Genetics. DOI: 10.1371/journal.pgen.1000993 PMID: 20585627
Eriksson N, Wu S, Do CB, Kiefer AK, Tung JY, Mountain JL, Hinds DA, Francke U (2012). “A genetic variant near olfactory receptor genes influences cilantro preference” Flavour. DOI: 10.1186/2044-7248-1-22 (not indexed in PubMed)
Farrer LA, Cupples LA, Haines JL et al. (1997). “Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis.” JAMA. DOI: 10.1001/jama.1997.03540390066028 PMID: 9343467
Ferreira MA, O'Donovan MC, Meng YA et al. (2008). “Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder” Nature Genetics. DOI: 10.1038/ng.209 (not indexed in PubMed)
Fishman D, Faulds G, Jeffery R et al. (1998). “The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis” Journal of Clinical Investigation. DOI: 10.1172/JCI2357 PMID: 9466966
Fishman D, Faulds G, Jeffery R et al. (1998). “The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis” Journal of Clinical Investigation. DOI: 10.1172/JCI2357 PMID: 9593774
Florez JC, Jablonski KA, Bayley N et al. (2006). “TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program” New England Journal of Medicine. DOI: 10.1056/NEJMoa062418 PMID: 16855264
Forsberg L, Lyrenas L, de Faire U et al. (2001). “A common functional C-T substitution polymorphism in the promoter region of the human catalase gene influences transcription factor binding, reporter gene transcription and is correlated to blood catalase levels” Free Radical Biology and Medicine. DOI: 10.1016/S0891-5849(00)00487-1 (not indexed in PubMed)
Frayling TM, Timpson NJ, Weedon MN et al. (2007). “A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity” Science. DOI: 10.1126/science.1141634 PMID: 17434869
Fushan AA, Simons CT, Slack JP, Manichaikul A, Drayna D (2009). “Allelic polymorphism within the TAS1R3 promoter is associated with human taste sensitivity to sucrose” Current Biology. DOI: 10.1016/j.cub.2009.06.015 PMID: 19559618
Gaedigk A, Ingelman-Sundberg M, Miller NA et al. (2018). “The Pharmacogene Variation (PharmVar) Consortium: incorporation of the Human Cytochrome P450 (CYP) Allele Nomenclature Database” Clinical Pharmacology and Therapeutics. DOI: 10.1002/cpt.910 (not indexed in PubMed)
Gammal RS, Court MH, Haidar CE et al. (2016). “Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for UGT1A1 and atazanavir prescribing” Clinical Pharmacology and Therapeutics. DOI: 10.1002/cpt.269 (not indexed in PubMed)
Gaughan DJ, Kluijtmans LA, Barbaux S et al. (2001). “The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations” Atherosclerosis. DOI: 10.1016/S0021-9150(00)00739-5 PMID: 11472746
Gilbody S, Lewis S, Lightfoot T (2007). “Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders: a HuGE review” American Journal of Epidemiology. DOI: 10.1093/aje/kwj347 (not indexed in PubMed)
Gloyn AL, Weedon MN, Owen KR et al. (2003). “Large-scale association studies of variants in genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes” Diabetes. DOI: 10.2337/diabetes.52.2.568 (not indexed in PubMed)
Gosso MF, de Geus EJ, van Belzen MJ et al. (2006). “The SNAP-25 gene is associated with cognitive ability: evidence from a family-based study in two independent Dutch cohorts” Molecular Psychiatry. DOI: 10.1038/sj.mp.4001868 (not indexed in PubMed)
Gottlieb DJ, O'Connor GT, Wilk JB (2007). “Genome-wide association of sleep and circadian phenotypes” BMC Medical Genetics. (not indexed in PubMed)
Grant SF, Reid DM, Blake G et al. (1996). “Reduced bone density and osteoporosis associated with a polymorphic Sp1 binding site in the collagen type I alpha 1 gene” Nature Genetics. DOI: 10.1038/ng0496-357 PMID: 8630502
Grant SF, Thorleifsson G, Reynisdottir I et al. (2006). “Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes” Nature Genetics. DOI: 10.1038/ng1732 PMID: 16415884
Green SA, Turki J, Innis M et al. (1994). “Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties” Biochemistry. DOI: 10.1021/bi00191a029 (not indexed in PubMed)
Greene CM, Bellgrove MA, Gill M, Robertson IH (2009). “Noradrenergic genotype predicts lapses in sustained attention” Neuropsychologia. DOI: 10.1016/j.neuropsychologia.2009.02.002 (not indexed in PubMed)
Hamblin MT, Di Rienzo A (2000). “Detection of the signature of natural selection in humans: evidence from the Duffy blood group locus” American Journal of Human Genetics. DOI: 10.1086/303051 (not indexed in PubMed)
Han J, Kraft P, Nan H et al. (2008). “A genome-wide association study identifies novel alleles associated with hair color and skin pigmentation” PLoS Genetics. DOI: 10.1371/journal.pgen.1000074 PMID: 18483556
Hazra A, Kraft P, Selhub J et al. (2008). “Common variants of FUT2 are associated with plasma vitamin B12 levels” Nature Genetics. DOI: 10.1038/ng.210 PMID: 18776911
Hicks JK, Bishop JR, Sangkuhl K et al. (2015). “Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 and CYP2C19 genotypes and dosing of selective serotonin reuptake inhibitors” Clinical Pharmacology and Therapeutics. DOI: 10.1002/cpt.147 (not indexed in PubMed)
Hoffmeyer S, Burk O, von Richter O et al. (2000). “Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo” Proceedings of the National Academy of Sciences. DOI: 10.1073/pnas.97.7.3473 (not indexed in PubMed)
Jeunemaitre X, Soubrier F, Kotelevtsev YV et al. (1992). “Molecular basis of human hypertension: role of angiotensinogen” Cell. DOI: 10.1016/0092-8674(92)90049-I PMID: 1394429
Jeunemaitre X, Soubrier F, Kotelevtsev YV et al. (1992). “Molecular basis of human hypertension: role of angiotensinogen” Cell. DOI: 10.1016/0092-8674(92)90049-J (not indexed in PubMed)
Johnson JA, Caudle KE, Gong L et al. (2017). “Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics-Guided Warfarin Dosing: 2017 Update” Clinical Pharmacology and Therapeutics. DOI: 10.1002/cpt.668 PMID: 28198005
Johnson JA, Caudle KE, Gong L et al. (2017). “Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for pharmacogenetics-guided warfarin dosing: 2017 update” Clinical Pharmacology and Therapeutics. DOI: 10.1002/cpt.668 (not indexed in PubMed)
Johnson JA, Liggett SB (2011). “Cardiovascular pharmacogenomics of adrenergic receptor signaling: clinical implications and future directions” Clinical Pharmacology and Therapeutics. DOI: 10.1038/clpt.2011.21 (not indexed in PubMed)
Jones A, Montgomery HE, Woods DR (2002). “Human performance: a role for the ACE genotype?” Exercise and Sport Sciences Reviews. DOI: 10.1097/00003677-200204000-00008 (not indexed in PubMed)
Jones SE, Tyrrell J, Wood AR et al. (2016). “Genome-wide association analyses in 128,266 individuals identifies new morningness loci and biological insights” PLoS Genetics. (not indexed in PubMed)
Kamberov YG, Wang S, Tan J et al. (2013). “Modeling recent human evolution in mice by expression of a selected EDAR variant” Cell. DOI: 10.1016/j.cell.2013.01.016 (not indexed in PubMed)
Katzenberg D, Young T, Finn L et al. (1998). “A CLOCK polymorphism associated with human diurnal preference” Sleep. DOI: 10.1093/sleep/21.6.569 PMID: 9779516
Kennedy C, ter Huurne J, Berkhout M et al. (2001). “Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color” Journal of Investigative Dermatology. DOI: 10.1046/j.0022-202x.2001.01420.x (not indexed in PubMed)
Kennedy C, ter Huurne J, Berkhout M et al. (2001). “Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color” Journal of Investigative Dermatology. DOI: 10.1046/j.0022-202x.2001.01421.x PMID: 11511307
Kim UK, Jorgenson E, Coon H, Leppert M, Risch N, Drayna D (2003). “Positional cloning of the human quantitative trait locus underlying taste sensitivity to phenylthiocarbamide” Science. DOI: 10.1126/science.1080190 PMID: 12595690
Kohno T, Shinmura K, Tosaka M et al. (1998). “Genetic polymorphisms and alternative splicing of the hOGG1 gene, that is involved in the repair of 8-hydroxyguanine in damaged DNA” Oncogene. DOI: 10.1038/sj.onc.1202096 (not indexed in PubMed)
Kroslak T, Laforge KS, Gianotti RJ et al. (2007). “The single nucleotide polymorphism A118G alters functional properties of the human mu opioid receptor” Journal of Neurochemistry. DOI: 10.1111/j.1471-4159.2007.04602.x (not indexed in PubMed)
Lamason RL, Mohideen MA, Mest JR et al. (2005). “SLC24A5, a putative cation exchanger, affects pigmentation in zebrafish and humans” Science. DOI: 10.1126/science.1120878 (not indexed in PubMed)
Lamason RL, Mohideen MA, Mest JR et al. (2005). “SLC24A5, a putative cation exchanger, affects pigmentation in zebrafish and humans” Science. DOI: 10.1126/science.1116238 PMID: 16357253
Leung WC, Hessel S, Meplan C et al. (2009). “Two common single nucleotide polymorphisms in the gene encoding beta-carotene 15,15'-monoxygenase alter beta-carotene metabolism in female volunteers” FASEB Journal. DOI: 10.1096/fj.08-121962 PMID: 19103647
Li H, Borinskaya S, Yoshimura K et al. (2009). “Refined geographic distribution of the oriental ALDH2*504Lys (nee 487Lys) variant” Annals of Human Genetics. DOI: 10.1111/j.1469-1809.2009.00517.x (not indexed in PubMed)
Loos RJ, Lindgren CM, Li S et al. (2008). “Common variants near MC4R are associated with fat mass, weight and risk of obesity” Nature Genetics. DOI: 10.1038/ng.140 PMID: 18454148
Lotta T, Vidgren J, Tilgmann C et al. (1995). “Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme” Biochemistry. DOI: 10.1021/bi00012a014 (not indexed in PubMed)
Lucia A, Gomez-Gallego F, Barroso I et al. (2005). “PPARGC1A genotype (Gly482Ser) predicts exceptional endurance capacity in European men” Journal of Applied Physiology. DOI: 10.1152/japplphysiol.00580.2004 (not indexed in PubMed)
Lunn RM, Langlois RG, Hsieh LL et al. (1999). “XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency” Cancer Research. (not indexed in PubMed)
Mann V, Hobson EE, Li B et al. (2001). “A COL1A1 Sp1 binding site polymorphism predisposes to osteoporotic fracture by affecting bone density and quality” Journal of Clinical Investigation. DOI: 10.1172/JCI10347 (not indexed in PubMed)
Miyamoto Y, Mabuchi A, Shi D et al. (2007). “A functional polymorphism in the 5' UTR of GDF5 is associated with susceptibility to osteoarthritis” Nature Genetics. DOI: 10.1038/ng2005 (not indexed in PubMed)
Mokone GG, Gajjar M, September AV et al. (2005). “The guanine-thymine dinucleotide repeat polymorphism within the tenascin-C gene is associated with Achilles tendon injuries” American Journal of Sports Medicine. DOI: 10.1177/0363546505275568 (not indexed in PubMed)
Mokone GG, Schwellnus MP, Noakes TD et al. (2006). “The COL5A1 gene and Achilles tendon pathology” Scandinavian Journal of Medicine and Science in Sports. DOI: 10.1111/j.1600-0838.2005.00439.x (not indexed in PubMed)
Munafò MR, Yalcin B, Willis-Owen SA, Flint J (2008). “Association of the dopamine D4 receptor (DRD4) gene and approach-related personality traits: meta-analysis and new data” Biological Psychiatry. DOI: 10.1016/j.biopsych.2008.04.009 (not indexed in PubMed)
Nair RP, Duffin KC, Helms C et al. (2009). “Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways” Nature Genetics. DOI: 10.1038/ng.311 PMID: 19169254
Nakayama M, Yasue H, Yoshimura M et al. (1999). “T-786→C mutation in the 5'-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm” Circulation. DOI: 10.1161/01.CIR.99.22.2864 (not indexed in PubMed)
Neville MJ, Johnstone EC, Walton RT (2004). “Identification and characterization of ANKK1: a novel kinase gene closely linked to DRD2 on chromosome band 11q23.1” Human Mutation. DOI: 10.1002/humu.20014 (not indexed in PubMed)
Nicholas B, Rudrasingham V, Nash S et al. (2007). “Association of Per1 and Npas2 with autistic disorder: support for the clock genes/social timing hypothesis” Molecular Psychiatry. (not indexed in PubMed)
Norton HL, Kittles RA, Parra E et al. (2007). “Genetic evidence for the convergent evolution of light skin in Europeans and East Asians” Molecular Biology and Evolution. DOI: 10.1093/molbev/msm203 (not indexed in PubMed)
Papassotiropoulos A, Stephan DA, Huentelman MJ et al. (2006). “Common Kibra alleles are associated with human memory performance” Science. DOI: 10.1126/science.1129837 PMID: 17008526
Parsons MJ, D'Souza UM, Arranz MJ et al. (2004). “The -1438A/G polymorphism in the 5-hydroxytryptamine type 2A receptor gene affects promoter activity” Biological Psychiatry. DOI: 10.1016/j.biopsych.2004.06.020 (not indexed in PubMed)
Parsons MJ, Lester KJ, Barclay NL et al. (2013). “Polymorphisms in the serotonin transporter and 5-HT2A receptor genes and self-reported sleep quality” Journal of Sleep Research. (not indexed in PubMed)
Paternoster L, Standl M, Chen CM et al. (2012). “Meta-analysis of genome-wide association studies identifies three new risk loci for atopic dermatitis” Nature Genetics. DOI: 10.1038/ng.1017 PMID: 22197932
Pepino MY, Love-Gregory L, Klein S, Abumrad NA (2012). “The fatty acid translocase gene CD36 and lingual lipase influence oral sensitivity to fat in obese subjects” Journal of Lipid Research. DOI: 10.1194/jlr.M021873 PMID: 22210925
Piel FB, Patil AP, Howes RE et al. (2013). “Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates” The Lancet. DOI: 10.1016/S0140-6736(12)61229-X (not indexed in PubMed)
Plante DT, Goldstein MR, Cook JD et al. (2015). “Effects of oral temazepam on sleep spindles during non-rapid eye movement sleep: a high-density EEG investigation” European Neuropsychopharmacology. (not indexed in PubMed)
Powe CE, Evans MK, Wenger J et al. (2013). “Vitamin D-binding protein and vitamin D status of black Americans and white Americans” New England Journal of Medicine. DOI: 10.1056/NEJMoa1306357 PMID: 24224556
Prior SJ, Hagberg JM, Paton CM et al. (2006). “DNA sequence variation in the promoter region of the VEGF gene impacts VEGF gene expression and maximal oxygen consumption” American Journal of Physiology-Heart and Circulatory Physiology. DOI: 10.1152/ajpheart.01033.2005 (not indexed in PubMed)
Prokopenko I, Langenberg C, Florez JC et al. (2009). “Variants in MTNR1B influence fasting glucose levels” Nature Genetics. DOI: 10.1038/ng.290 PMID: 19060907
Raleigh SM, van der Merwe L et al. (2009). “Variants within the MMP3 gene are associated with Achilles tendinopathy” Journal of Science and Medicine in Sport. (not indexed in PubMed)
Ravn-Haren G, Olsen A, Tjonneland A et al. (2006). “Associations between GPX1 Pro198Leu polymorphism, erythrocyte GPX activity, alcohol consumption and breast cancer risk in a prospective cohort study” Carcinogenesis. DOI: 10.1093/carcin/bgi267 (not indexed in PubMed)
Relling MV, Schwab M, Whirl-Carrillo M et al. (2019). “Clinical Pharmacogenetics Implementation Consortium guideline for thiopurine dosing based on TPMT and NUDT15 genotypes: 2018 update” Clinical Pharmacology and Therapeutics. DOI: 10.1002/cpt.1304 (not indexed in PubMed)
Retey JV, Adam M, Honegger E et al. (2005). “A functional genetic variation of adenosine deaminase affects the duration and intensity of deep sleep in humans” Proceedings of the National Academy of Sciences. DOI: 10.1073/pnas.0505414102 PMID: 16221767
Retey JV, Adam M, Khatami R et al. (2007). “A genetic variation in the adenosine A2A receptor gene (ADORA2A) contributes to individual sensitivity to caffeine effects on sleep” Clinical Pharmacology and Therapeutics. DOI: 10.1038/sj.clpt.6100102 PMID: 17329997
Retey JV, Adam M, Khatami R et al. (2007). “A genetic variation in the adenosine A2A receptor gene (ADORA2A) contributes to individual sensitivity to caffeine effects on sleep” Clinical Pharmacology and Therapeutics. DOI: 10.1038/sj.clpt.6100102 (not indexed in PubMed)
Riha RL, Brander P, Vennelle M et al. (2005). “Tumour necrosis factor-alpha (-308) gene polymorphism in obstructive sleep apnoea-hypopnoea syndrome” European Respiratory Journal. (not indexed in PubMed)
Rip J, Nierman MC, Ross CJ et al. (2006). “Lipoprotein lipase S447X: a naturally occurring gain-of-function mutation” Arteriosclerosis, Thrombosis, and Vascular Biology. DOI: 10.1161/01.ATV.0000202979.59523.0f (not indexed in PubMed)
Rodrigues SM, Saslow LR, Garcia N et al. (2009). “Oxytocin receptor genetic variation relates to empathy and stress reactivity in humans” Proceedings of the National Academy of Sciences. DOI: 10.1073/pnas.0909579106 PMID: 19948959
Rosenwasser LJ, Klemm DJ, Dresback JK et al. (1995). “Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy” Clinical and Experimental Allergy. DOI: 10.1111/j.1365-2222.1995.tb03428.x (not indexed in PubMed)
Samani NJ, Erdmann J, Hall AS et al. (2007). “Genomewide association analysis of coronary artery disease” New England Journal of Medicine. DOI: 10.1056/NEJMoa072366 (not indexed in PubMed)
Scott SA, Sangkuhl K, Stein CM et al. (2013). “Clinical Pharmacogenetics Implementation Consortium guidelines for CYP2C19 genotype and clopidogrel therapy: 2013 update” Clinical Pharmacology and Therapeutics. DOI: 10.1038/clpt.2013.105 PMID: 23698643
SEARCH Collaborative Group, Link E, Parish S et al. (2008). “SLCO1B1 variants and statin-induced myopathy — a genomewide study” New England Journal of Medicine. DOI: 10.1056/NEJMoa0801936 PMID: 18650507
Siegel D, Anwar A, Winski SL et al. (2001). “Rapid polyubiquitination and proteasomal degradation of a mutant form of NAD(P)H:quinone oxidoreductase 1” Molecular Pharmacology. (not indexed in PubMed)
Sladek R, Rocheleau G, Rung J et al. (2007). “A genome-wide association study identifies novel risk loci for type 2 diabetes” Nature. DOI: 10.1038/nature05616 PMID: 17293876
Sladek R, Rocheleau G, Rung J et al. (2007). “A genome-wide association study identifies novel risk loci for type 2 diabetes” Nature. DOI: 10.1038/nature05616 (not indexed in PubMed)
Sollid LM, Markussen G, Ek J et al. (1989). “Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer” Journal of Experimental Medicine. DOI: 10.1084/jem.169.1.345 PMID: 2909659
Stefansson H, Rye DB, Hicks A et al. (2007). “A genetic risk factor for periodic limb movements in sleep” New England Journal of Medicine. DOI: 10.1056/NEJMoa072743 PMID: 17634447
Sulem P, Gudbjartsson DF, Stacey SN et al. (2007). “Genetic determinants of hair, eye and skin pigmentation in Europeans” Nature Genetics. DOI: 10.1038/ng.2007.13 (not indexed in PubMed)
Sulem P, Gudbjartsson DF, Stacey SN et al. (2007). “Genetic determinants of hair, eye and skin pigmentation in Europeans” Nature Genetics. DOI: 10.1038/ng.2007.13 PMID: 17952075
Sulem P, Gudbjartsson DF, Stacey SN et al. (2008). “Two newly identified genetic determinants of pigmentation in Europeans” Nature Genetics. DOI: 10.1038/ng.160 PMID: 18488028
Sutton A, Khoury H, Prip-Buus C et al. (2003). “The Ala16Val genetic dimorphism modulates the import of human manganese superoxide dismutase into rat liver mitochondria” Pharmacogenetics. DOI: 10.1097/00008571-200303000-00004 PMID: 12618592
Sutton A, Khoury H, Prip-Buus C et al. (2003). “The Ala16Val genetic dimorphism modulates the import of human manganese superoxide dismutase into rat liver mitochondria” Pharmacogenetics. DOI: 10.1097/00008571-200303000-00004 (not indexed in PubMed)
Tanimoto K, Yoshiga K, Eguchi H et al. (2003). “Hypoxia-inducible factor-1alpha polymorphisms associated with enhanced transactivation capacity, implying clinical significance” Carcinogenesis. DOI: 10.1093/carcin/bgg178 (not indexed in PubMed)
Theken KN, Lee CR, Gong L et al. (2020). “Clinical Pharmacogenetics Implementation Consortium guideline (CPIC) for CYP2C9 and nonsteroidal anti-inflammatory drugs” Clinical Pharmacology and Therapeutics. DOI: 10.1002/cpt.1830 (not indexed in PubMed)
Valverde P, Healy E, Jackson I et al. (1995). “Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans” Nature Genetics. DOI: 10.1038/ng1195-328 PMID: 7581459
Viola AU, Archer SN, James LM et al. (2007). “PER3 polymorphism predicts sleep structure and waking performance” Current Biology. DOI: 10.1016/j.cub.2007.01.073 PMID: 17346965
Wang TJ, Zhang F, Richards JB et al. (2010). “Common genetic determinants of vitamin D insufficiency: a genome-wide association study” Lancet. DOI: 10.1016/S0140-6736(10)60588-0 PMID: 20541252
Watson CJ, Webb NJ, Bottomley MJ et al. (2000). “Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production” Cytokine. DOI: 10.1006/cyto.2000.0711 PMID: 11023662
Willcox BJ, Donlon TA, He Q et al. (2008). “FOXO3A genotype is strongly associated with human longevity” Proceedings of the National Academy of Sciences. DOI: 10.1073/pnas.0801030105 PMID: 18765803
Willer CJ, Schmidt EM, Sengupta S et al. (2013). “Discovery and refinement of loci associated with lipid levels” Nature Genetics. DOI: 10.1038/ng.2797 (not indexed in PubMed)
Wilson AG, Symons JA, McDowell TL et al. (1997). “Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation” Proceedings of the National Academy of Sciences. DOI: 10.1073/pnas.94.7.3195 (not indexed in PubMed)
Winkelmann J, Schormair B, Lichtner P et al. (2007). “Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions” Nature Genetics. DOI: 10.1038/ng2099 PMID: 17637780
Woon PY, Kaisaki PJ, Braganca J et al. (2007). “Aryl hydrocarbon receptor nuclear translocator-like (BMAL1) is associated with susceptibility to hypertension and type 2 diabetes” Proceedings of the National Academy of Sciences. (not indexed in PubMed)
Wüst S, Van Rossum EF, Federenko IS et al. (2004). “Common polymorphisms in the glucocorticoid receptor gene are associated with adrenocortical responses to psychosocial stress” Journal of Clinical Endocrinology and Metabolism. DOI: 10.1210/jc.2003-031148 (not indexed in PubMed)
Yang N, MacArthur DG, Gulbin JP et al. (2003). “ACTN3 genotype is associated with human elite athletic performance” American Journal of Human Genetics. DOI: 10.1086/377590 PMID: 12879365
Yoshiura K, Kinoshita A, Ishida T et al. (2006). “A SNP in the ABCC11 gene is the determinant of human earwax type” Nature Genetics. DOI: 10.1038/ng1733 (not indexed in PubMed)
Zeggini E, Weedon MN, Lindgren CM et al. (2007). “Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes” Science. DOI: 10.1126/science.1142364 (not indexed in PubMed)
This sample report is for demonstration purposes only and does not represent any individual's actual genetic profile. See our Terms of Service for full disclaimers.